financetom
Business
financetom
/
Business
/
Why Beneficient (BENF) Shares Are Getting Hammered
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Beneficient (BENF) Shares Are Getting Hammered
Apr 16, 2024 10:26 AM

Beneficient shares are trading lower by 17% to $0.07 during Tuesday’s session after the company announced a 1-for-80 reverse stock split of its Class A and Class B common stock, effective April 18.

The split aims to comply with Nasdaq’s minimum bid price requirement. After the split, every 80 shares will be consolidated into one share, with adjustments to equity awards and convertible securities. The total authorized shares will be reduced proportionally.

Fractional shares will be rounded up, and holders need not take action if shares are held electronically. The outstanding shares are expected to decrease from about 287.87 million to approximately 3.6 million post-split.

See Also: Intel and Nvidia Reveal New Products for China, Adapt AI Chip Strategies in Response to US Sanctions

How To Buy BENF Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Beneficient’s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, BENF has a 52-week high of $16.50 and a 52-week low of $0.048.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kymera Therapeutics Unveils $200 Million Public Offering -- Shares Slip After Hours
Kymera Therapeutics Unveils $200 Million Public Offering -- Shares Slip After Hours
Aug 19, 2024
04:23 PM EDT, 08/19/2024 (MT Newswires) -- Kymera Therapeutics ( KYMR ) said late Monday that it kicked off a $200 million underwritten public offering of common shares and pre-funded warrants to purchase shares. The company intends to grant underwriters a 30-day option to purchase up to $30 million additional shares in the offering. Kymera intends to use the net...
US overnight trading platform Blue Ocean completes fix for capacity issues
US overnight trading platform Blue Ocean completes fix for capacity issues
Aug 19, 2024
(Reuters) - Trading platform Blue Ocean Technologies LLC on Monday completed a platform upgrade that will boost capacity several hundredfold, two weeks after its overnight trading system crashed in the midst of a global market sell-off, the company said. The fix underscores the need for upgrades to cope with massive growth in retail overnight trading, especially as investors try to...
Azek Insider Sold Shares Worth $782,755, According to a Recent SEC Filing
Azek Insider Sold Shares Worth $782,755, According to a Recent SEC Filing
Aug 19, 2024
04:20 PM EDT, 08/19/2024 (MT Newswires) -- Jonathan Skelly, President, Residential & Commercial, on August 16, 2024, sold 19,022 shares in Azek ( AZEK ) for $782,755. Following the Form 4 filing with the SEC, Skelly has control over a total of 189,974 shares of the company, with 189,974 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1782754/000162828024037696/xslF345X03/wk-form4_1724098315.xml Price: 40.80, Change: +0.01, Percent...
Hagerty Insider Sold Shares Worth $343,265, According to a Recent SEC Filing
Hagerty Insider Sold Shares Worth $343,265, According to a Recent SEC Filing
Aug 19, 2024
04:28 PM EDT, 08/19/2024 (MT Newswires) -- Robert I Kauffman, Director, on August 15, 2024, sold 31,570 shares in Hagerty ( HGTY ) for $343,265. Following the Form 4 filing with the SEC, Kauffman has control over a total of 5,352,435 shares of the company, with 53,474 shares held directly and 5,298,961 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1840776/000184077624000183/xslF345X03/wk-form4_1724098980.xml Price: 11.38, Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved